94 related articles for article (PubMed ID: 3614463)
1. Organ distribution of fibrinogen-bound methotrexate in mice with Gardner lymphosarcoma.
Slavíková V; Dyr JE; Motycka K; Pristoupilová K; Holý P; Slavík K
Neoplasma; 1987; 34(3):269-76. PubMed ID: 3614463
[TBL] [Abstract][Full Text] [Related]
2. The chemotherapy of C3H mice bearing Gardner lymphosarcoma with bovine fibrinogen-methotrexate derivative.
Motycka K; Slavík K; Dyr JE; Balcarová A; Vodrázka Z
Neoplasma; 1981; 28(1):3-10. PubMed ID: 6895104
[TBL] [Abstract][Full Text] [Related]
3. Effect of free and bovine fibrinogen-bound methotrexate and dibromoaminopterin on the dissemination of solid Gardner lymphosarcoma.
Motycka K; Dyr JE; Macáková A; Slavík K
Neoplasma; 1982; 29(2):197-204. PubMed ID: 6896744
[TBL] [Abstract][Full Text] [Related]
4. Distribution and pharmacokinetics of methotrexate in localized chemotherapy of solid Gardner's lymphosarcoma.
Slavíková V; Motycka K; Slavík K; Spacek P; Cihar R; Balcarová A
Neoplasma; 1978; 25(2):211-6. PubMed ID: 580447
[TBL] [Abstract][Full Text] [Related]
5. The use of protein as a carrier of methotrexate for experimental cancer chemotherapy. II. Chemotherapy of Gardner lymphosarcoma with pea seed lectin-methotrexate derivative.
Bures L; Motycka K; Bostík J; Slavík K; Jirásek A
Neoplasma; 1986; 33(4):409-16. PubMed ID: 3762803
[TBL] [Abstract][Full Text] [Related]
6. Effect of methotrexate sorbed on modified 2-hydroxyethylmethacrylate carriers in mice of C3H strain with a solid Gardner lymphosarcoma.
Motycka K; Slavík ; kocovská A; Cihar R; Spacek P; Kubín M
Neoplasma; 1977; 24(3):271-6. PubMed ID: 578291
[TBL] [Abstract][Full Text] [Related]
7. Localized chemotherapy of Gardner's lymphosarcoma of C3H mice using combinations of carrier-sorbed antifolics and detoxicating tetrahydrofolates.
Motycka K; Slavík K; Balcarová A; Spacek P; Kubín M
Czech Med; 1981; 4(1-2):14-24. PubMed ID: 6973453
[TBL] [Abstract][Full Text] [Related]
8. Treatment of C3H mice bearing solid Gardner lymphosarcoma with vaccine prepared from Corynebacterium parvum combined with methotrexate and Alexan.
Motycka K; Chudomel V; Bednár M; Bostík J
Arch Immunol Ther Exp (Warsz); 1984; 32(4):413-9. PubMed ID: 6549500
[TBL] [Abstract][Full Text] [Related]
9. Treatment of solid Gardner lymphosarcoma with methotrexate sorbed on 2-hydroxyethylmethacrylate polymer in combination with leukovorin.
Motycka K; Slavík K; Balcarbová A; Cihar R; Spacek P; Kubín M
Neoplasma; 1978; 25(2):217-25. PubMed ID: 306074
[TBL] [Abstract][Full Text] [Related]
10. Tumor and tissue distribution of a methotrexate-anti-EL4 immunoglobulin conjugate in EL4 lymphoma-bearing mice.
Uadia P; Blair AH; Ghose T
Cancer Res; 1984 Oct; 44(10):4263-6. PubMed ID: 6467187
[TBL] [Abstract][Full Text] [Related]
11. Changes in metabolism, food and water intake of C3H mice following transplantation of Gardner lymphosarcoma (LSG).
Bostík J; Vybíral S; Spundová M
Physiol Bohemoslov; 1988; 37(4):325-32. PubMed ID: 2973618
[TBL] [Abstract][Full Text] [Related]
12. The effect of fibrinogen-methotrexate derivatives on HeLa cell growth.
Dyr JE; Hermanová E; Slavík K; Vodrázka Z
Neoplasma; 1986; 33(4):401-7. PubMed ID: 3531894
[TBL] [Abstract][Full Text] [Related]
13. The use of protein as a carrier of methotrexate for experimental cancer chemotherapy. III. Human serum albumin-methotrexate derivative, its preparation and basic testing.
Bures L; Bostík J; Motycka K; Spundová M; Rehák L
Neoplasma; 1988; 35(3):329-42. PubMed ID: 3405341
[TBL] [Abstract][Full Text] [Related]
14. Retention of tritiated methotrexate in a transplantable mouse glioma.
Tator CH
Cancer Res; 1976 Sep; 36(9 pt.1):3058-66. PubMed ID: 975073
[TBL] [Abstract][Full Text] [Related]
15. Control of solid tumor metastases with a high-molecular-weight derivative of methotrexate.
Chu BC; Whiteley JM
J Natl Cancer Inst; 1979 Jan; 62(1):79-82. PubMed ID: 281578
[TBL] [Abstract][Full Text] [Related]
16. The use of protein as a carrier of methotrexate for experimental cancer chemotherapy. V. Alternative method for preparation of serum albumin-methotrexate derivative.
Bures L; Lichý A; Bostík J; Spundová M
Neoplasma; 1990; 37(3):225-31. PubMed ID: 2370913
[TBL] [Abstract][Full Text] [Related]
17. Effect of methotrexate-monoclonal anti-prostatic acid phosphatase antibody conjugate on human prostate tumor.
Deguchi T; Chu TM; Leong SS; Horoszewicz JS; Lee CL
Cancer Res; 1986 Aug; 46(8):3751-5. PubMed ID: 3731053
[TBL] [Abstract][Full Text] [Related]
18. The effect of entrapment in liposomes on the in vivo distribution of [3H]methotrexate in a primate.
Kimelberg HK; Tracy TF; Biddlecome SM; Bourke RS
Cancer Res; 1976 Aug; 36(8):2949-57. PubMed ID: 819137
[TBL] [Abstract][Full Text] [Related]
19. Distribution and degradation of [3H]methotrexate after intravenous and cerebral intraventricular injection in primates.
Kimelberg HK; Biddlecome SM; Bourke RS
Cancer Res; 1977 Jan; 37(1):157-65. PubMed ID: 401470
[TBL] [Abstract][Full Text] [Related]
20. Intracellular pharmacokinetics of methotrexate polyglutamates in human breast cancer cells. Selective retention and less dissociable binding of 4-NH2-10-CH3-pteroylglutamate4 and 4-NH2-10-CH3-pteroylglutamate5 to dihydrofolate reductase.
Jolivet J; Chabner BA
J Clin Invest; 1983 Sep; 72(3):773-8. PubMed ID: 6193143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
